Investor profile
MIG Capital has backed 18 European tech companies across 23 funding rounds between 2017 and 2026, joining rounds totalling €412M. Most active in Software and Healthtech. Data as of 6 Aug 2026.
Also recorded as: MIG · MIG AG · MIG Capital AG · MIG Funds
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| AMSilk | Germany | 2 | €102M |
| IOmx Therapeutics | Germany | 1 | €65M |
| Konux | Germany | 3 | €40M |
| playermaker | UK | 1 | €38M |
| Temedica | Germany |
| Company | Stage | Amount | Date |
|---|---|---|---|
| IOmx Therapeutics | Series B | €65M | 2021-10 |
| AMSilk | Other | €52M | 2025-09 |
| playermaker | Other | €38M | 2022-06 |
| AMSilk |
| 1 |
| €25M |
| Mimi | Germany | 1 | €22M |
| Kewazo | Germany | 3 | €17M |
| German Bionic | Germany | 1 | €16M |
| NcodiN | France | 1 | €16M |
| Innatera Nanosystems | Netherlands | 1 | €15M |
| Talpasolutions | Germany | 1 | €15M |
| IQM | Finland | 1 | €12M |
| Luffy AI | UK | 1 | €9.5M |
| Liva Healthcare | Denmark | 1 | €8.0M |
| Hawkcell | France | 1 | €5.0M |
| Inbolt | France | 1 | €3.0M |
| GlassPoint | Germany | 1 | €2.3M |
| NavVis | Germany | 1 | €0 |
| €25M |
| 2023-04 |
| AMSilk | Series C | €25M | 2023-04 |
| Temedica | Series B | €25M | 2022-11 |
| Mimi | Series B | €22M | 2021-12 |
| Konux | Other | €20M | 2018-02 |
| German Bionic | Series A | €16M | 2020-12 |
| NcodiN | Seed | €16M | 2025-11 |
